Soluble levels of receptor for advanced glycation endproducts and dysfunctional high-density lipoprotein in persons infected with human immunodeficiency virus: ACTG NWCS332.

Medicine
Theodoros KelesidisAnn Marie Schmidt

Abstract

The role of high-density lipoprotein (HDL) function and advanced glycation end products (AGEs) in HIV-related atherosclerotic cardiovascular disease (CVD) is unclear. Both glycation and oxidation (HDLox) are major modifications of HDL that can alter its composition and function. Therefore, we explored the longitudinal association of HDLox with progression of glycation, as evaluated by measurement of circulating forms of receptor for AGE that predict morbidity (soluble Receptors for Advanced Glycation Endproducts [sRAGE], endogenous secretory Receptors for Advanced Glycation Endproducts [esRAGE]), in people with HIV-1 (PWH; HIV-1) and uninfected (HIV-1) individuals.We retrospectively assessed if levels of plasma sRAGE and esRAGE and HDL function (reduced antioxidant function is associated with increased HDL lipid hydroperoxide content; HDLox) in a subset of participants (n = 80) from a prospective 3-year study (AIDS Clinical Trials Group A5078). Primary outcomes were baseline and yearly rates of change over 96 of 144 weeks (Δ) in HDLox in HIV-1 versus uninfected HIV-1 controls (noted as HIV-1).Higher baseline levels of sRAGE in PWH on effective anti-retroviral therapy and with low CVD risk, but not in HIV-1 persons, were indepen...Continue Reading

References

Nov 9, 1989·The New England Journal of Medicine·D J Gordon, B M Rifkind
Apr 18, 2000·Diabetologia·C C HedrickA L Peters
Feb 26, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Colomba FalconeDiego Geroldi
Dec 15, 2007·The Journal of Clinical Investigation·Evis HarjaAnn Marie Schmidt
Jun 9, 2009·Diabetes Care·Peter S KimColleen Hadigan
Jan 26, 2010·Biochemical Pharmacology·Shi Fang YanAnn Marie Schmidt
Feb 10, 2011·Nature Reviews. Cardiology·Mohamad NavabAlan M Fogelman
Oct 1, 2011·Journal of Lipid Research·Theodoros KelesidisOtto O Yang
Jul 6, 2012·Acta Diabetologica·Francesco PiarulliAnnunziata Lapolla
Jan 1, 2013·Current Opinion in HIV and AIDS·Edwin LeeansyahJohan K Sandberg
Mar 21, 2013·Lipids in Health and Disease·Theodoros KelesidisJudith S Currier
Aug 30, 2014·Endocrinology and Metabolism Clinics of North America·Theodoros Kelesidis, Judith S Currier
Aug 9, 2015·Diabetes·Gurdip DaffuAnn Marie Schmidt
Mar 28, 2017·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Theodoros KelesidisJudith S Currier

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay

Software Mentioned

STAT
SAS

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.